Latest Views & News

Omega Diagnostics Regulatory Failure a sign of incompetence but does not affect business model: it is still shite & doomed

By Tom Winnifrith | Friday 11 March 2022

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Oh dear. Oh dear. The chaps running Omega Diagnostics (ODX) really are incompetent poltroons.  I wonder how my favourite Saltire waving troll Craig Inglis – who first inspired me to start investigating this POS -  feels about the latest dire news: The UK Health Security Agency rejecting an application for approval of the professional-use VISITECT® COVID-19 Antigen test. Ooops.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Monday »


Just 26 days to go: Book Now!

Sunday »


Me and “The Millionaire Next Door”

Tuesday »


Synectics – a recovery Buy?



Malcolm Stacey is Moving House

Monday »


Wood Group - a Buy (again)?



Video: Bubbles always implode